Advanced Heart Failure and Transplant Cardiology · Englewood, NJ
NPI
1235376864
Since 2009
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
350 Engle St
Englewood, NJ, 07631
Phone (201) 894-3690
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
369 services
Medicare patients, 2024
103
Average age 69
Drug cost, 2024
$798K
506 prescriptions
Company payments, 2025
$9,806
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saurabh Kapoor was code 99233 (hospital e&m - subsequent), 127 times for 34 patients. In total Saurabh Kapoor billed 369 services in 20 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 127 | 34 | $95.80 | $12K |
| 99214 Office E&M - Established | Facility | 72 | 41 | $76.61 | $5,516 |
| 99291 Critical Care E&M | Facility | 56 | 17 | $161.98 | $9,071 |
| 99152 Anesthesia | Facility | 12 | 11 | $10.17 | $122 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $145.30 | $1,598 |
By year: 2022 $65K for 640 services; 2023 $45K for 419 services; 2024 $38K for 369 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saurabh Kapoor prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 62 prescriptions and refills. In total Saurabh Kapoor wrote 506 Medicare prescriptions that cost $798K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 62 | 118 | 18 | $78K |
| Spironolactone Generic | 38 | 93 | 16 | $220 |
| Farxiga Dapagliflozin Propanediol | 28 | 62 | Under 11 | $35K |
| Jardiance Empagliflozin | 26 | 44 | Under 11 | $25K |
| Atorvastatin Calcium Generic | 25 | 53 | 12 | $82.08 |
| Carvedilol Generic | 22 | 59 | 11 | $188 |
| Hydralazine Hcl Generic | 21 | 37 | Under 11 | $421 |
| Micafungin Micafungin Sodium | 20 | 20 | Under 11 | $7,604 |
| Torsemide Generic | 17 | 47 | Under 11 | $256 |
| Amphotericin B Liposome Generic | 15 | 15 | Under 11 | $106K |
| Verquvo Vericiguat | 14 | 22 | Under 11 | $15K |
| Furosemide Generic | 14 | 34 | Under 11 | $61.61 |
| Vyndamax Tafamidis | 13 | 19 | Under 11 | $422K |
| Potassium Chloride Generic | 12 | 28 | Under 11 | $221 |
| Pantoprazole Sodium Generic | 12 | 20 | Under 11 | $117 |
Brand drugs: - claims; generic drugs: 338 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saurabh Kapoor $9,806 ($9,806 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $8,153.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 10 | $8,153 |
| Abbott Laboratories ABT | 17 | $1,173 |
| Eurofins Viracor, LLC | 1 | $128 |
| Merck Sharp & Dohme LLC MRK | 5 | $83.24 |
| BridgeBio Pharma, Inc. BBIO | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $35.21 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.16 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $29.43 |
| Medtronic, Inc. MDT | 1 | $25.25 |
| Impulse Dynamics (USA) Inc. | 1 | $23.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.